Cohance to attend investor conferences in May 2026
Cohance Lifesciences management will attend Citi's 2026 Pan-Asia Investor Conference in Singapore and B&K's 16th Annual Investor Conference in Mumbai in May 2026. The company confirmed that no unpublished price-sensitive information will be disclosed during these meetings.
*this image is generated using AI for illustrative purposes only.
Cohance Lifesciences Limited has informed the stock exchanges that its management will participate in upcoming analyst and institutional investor meetings. These interactions are scheduled to take place in May 2026.
Conference Schedule
The company management will attend the following conferences to engage with investors and analysts. The schedule is subject to change based on exigencies.
| Date | Conferences | Location | Group/One-one |
|---|---|---|---|
| May 18-20, 2026 | Citi's 2026 Pan-Asia Investor Conference | Singapore (Virtual) |
Group/One-one |
| May 27, 2026 | B&K's 16th Annual Investor Conference | Mumbai |
Disclosure Compliance
The company stated that no unpublished price-sensitive information will be shared during these interactions. The intimation was submitted to BSE Limited and National Stock Exchange of India Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Cohance Lifesciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.94% | -12.72% | +18.01% | -31.24% | -60.78% | -18.18% |
What strategic updates or pipeline milestones might Cohance Lifesciences' management highlight to institutional investors at these conferences following the rebranding from Suven Pharmaceuticals?
How could increased visibility among Pan-Asia institutional investors influence foreign portfolio investment flows into Cohance Lifesciences over the next 12 months?
What key financial or operational metrics are analysts likely to scrutinize most closely given the company's recent transition to the Cohance Lifesciences brand?
16
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
